BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 27 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,774 | -36.3% | 2,900,000 | -34.1% | 0.01% | -41.7% |
| Q1 2024 | $4,357 | -3.5% | 4,400,000 | 0.0% | 0.01% | -7.7% |
| Q4 2023 | $4,513 | +3.5% | 4,400,000 | 0.0% | 0.01% | 0.0% |
| Q3 2023 | $4,359 | -2.2% | 4,400,000 | 0.0% | 0.01% | -7.1% |
| Q2 2023 | $4,459 | -2.1% | 4,400,000 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $4,555 | -4.6% | 4,400,000 | 0.0% | 0.02% | -5.9% |
| Q4 2022 | $4,777 | -99.9% | 4,400,000 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $4,407,000 | -0.1% | 4,400,000 | 0.0% | 0.02% | 0.0% |
| Q2 2022 | $4,412,000 | -0.9% | 4,400,000 | 0.0% | 0.02% | +13.3% |
| Q1 2022 | $4,452,000 | -2.8% | 4,400,000 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $4,578,000 | +4.5% | 4,400,000 | 0.0% | 0.02% | -6.2% |
| Q3 2021 | $4,379,000 | -0.9% | 4,400,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $4,420,000 | – | 4,400,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |